Trial Profile
Randomized, double-blind, multicenter, active controlled parallel group study to evaluate the efficacy and safety of celecoxib suspension compared to naproxen suspension in patients with JRA
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Apr 2008
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Naproxen
- Indications Juvenile rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Pfizer
- 28 Apr 2008 New trial record.